Delivery Order SPE2DB20D3101-SPE2DB23FRVJ1
Award Date 8/18/23
Potential Completion Date 8/21/23
Potential Value $1.5K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, valued at $1,415.28, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567379879 CLOBAZAM 2.5 MG/ML SUSPENSION 120ML, a pharmaceutical product. The contract is a firm fixed-price delivery order with a completion date of February 26, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, valued at $3,111.86, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CLOBAZAM 10 MG TABLET 100S, a pharmaceutical product, and is designated as a Firm Fixed Price Delivery Order with a completion date of February 21, 2025. The contract is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award, with a ceiling value of $1,238.28, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a delivery order for the supply of 4565405730 - CLOBAZAM 2.5 MG/ML SUSPENSION 120ML, a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of August 12, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this contract as well as several...
- This federal contract award, valued at $1,209.71, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Clobazam 2.5 mg/ml suspension in 120 ml quantities. This is a Firm Fixed Price Delivery Order contract with a completion date of December 22, 2023. The contract was awarded on December 21, 2023 and was not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that...
- This federal contract award, valued at $1,565.53, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4562966683 CLOBAZAM 10 MG TABLET 100S, a pharmaceutical product, with a period of performance through December 4, 2023. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. This award is not associated with a set-aside designation, indicating open...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,377.25, is a delivery order for the supply of 4567825065 - CLOBAZAM 10 MG TABLET 100S. The contract has an ultimate completion date of April 8, 2025 and is a firm fixed price contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,275.60 fixed-price delivery order is for the supply of 4563636579 CLOBAZAM 10 MG TABLET 100S, with a completion date of February 13, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award, valued at $1,977.18, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a Delivery Order, is for the supply of CLOBAZAM 10 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of March 4, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania. The contract is a delivery order valued at $1,683.38 for the supply of 100 units of the medication CLOBAZAM 10 MG TABLET. The contract has an ultimate completion date of July 14, 2025 and is a firm fixed-price arrangement. Amerisourcebergen Drug Corp holds a significant...
- This is a $1,307.57 firm-fixed-price delivery order awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of 4565334058 – CLOBAZAM 2.5 MG/ML SUSPENSION 120ML. The order has an ultimate completion date of August 5, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple indefinite delivery contracts (IDCs) by DLA and other federal agencies to provide a wide range of critical medical supplies and medications to support military...